Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.

NCT ID: NCT03600129

Last Updated: 2019-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-25

Study Completion Date

2019-10-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Laparoscopic prostatectomy (LP) is characterized by substantial tissue trauma, despite its minimally -invasive approach. Although postoperative pain intensity is lower when compared to open procedures, the use of opioids is common. Retrospective review of available LP cases revealed that although analgesic demand varied, nearly all of our LP patients required opioids postoperatively. Bilateral Quadratus Lumborum Block (QLB), being one of relatively new features of regional anesthesia, offers good analgesia of abdominal wall, with the potential for control of visceral pain. This study was established to evaluate its effectiveness in alleviating pain after radical prostatectomy in a double - blind, placebo - controlled manner.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Double blind, placebo-controlled, randomised
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Solution used for block (local anesthetic or placebo) is known to anesthetist not involved in patient's care.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

QLB with 0,375% ropivacaine

Group Type EXPERIMENTAL

Qadratus Lumborum Block

Intervention Type PROCEDURE

Bilateral, ultrasound - guided Quadratus Lumborum Block

30 milliliters of 0.375% Ropivacaine

Intervention Type DRUG

30 milliliters of 0.375% Ropivacaine used for Quadratus Lumborum Block

QLB with 0,9% NaCl

Group Type PLACEBO_COMPARATOR

Qadratus Lumborum Block

Intervention Type PROCEDURE

Bilateral, ultrasound - guided Quadratus Lumborum Block

30 milliliters of 0.9% NaCl

Intervention Type DRUG

30 milliliters of 0.9% NaCl used for Quadratus Lumborum Block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qadratus Lumborum Block

Bilateral, ultrasound - guided Quadratus Lumborum Block

Intervention Type PROCEDURE

30 milliliters of 0.375% Ropivacaine

30 milliliters of 0.375% Ropivacaine used for Quadratus Lumborum Block

Intervention Type DRUG

30 milliliters of 0.9% NaCl

30 milliliters of 0.9% NaCl used for Quadratus Lumborum Block

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA status less or equal 3
* Scheduled for transperitoneal or extraperitoneal endoscopic prostatectomy
* Able to understand information provided and to sign the informed consent for participation in the study

Exclusion Criteria

* known allergy to local anesthetics and opioids
* infection in the area of block placement
* known chronic use of opioids, gabapentinoids and tricyclic antidepressants
* mental inability to understand the principles and rules of patient-controlled analgesia pump
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre of Postgraduate Medical Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bartosz Horosz, MD

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Malgorzata Malec-Milewska, MD, PhD

Role: STUDY_CHAIR

Orlowski Hospital, Centre of Postgraduate Medical Education, Department of Anesthesiology and Intensive Care

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care

Warsaw, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

83/PB/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Regional Analgesia After Cesarean Section
NCT03244540 COMPLETED PHASE4